Charities' Funding Contributes to UK Medical Research Excellence Published: 16 June 2017 New figures released today reveal that AMRC members funded over £1.6 billion of medical research across the UK in 2016, the biggest proportion of public funding, compared to £1.04 billion from the National Institute for Health Research, and £0.93 billion from the Medical Research Council. This funding stimulated more than £500 million in further investment during 2016 from international funders, government funders, industry, universities and other charities. Aisling Burnand MBE, Chief Executive at AMRC commented: “At a time when there is uncertainty about the potential impact of Brexit on the UK’s medical research sector, it is vital that charitable funding can continue to have such impact. Although we are justly proud of the uniqueness of the role charities have to play in funding UK medical research, we are not complacent about the apparent continued growth. We know that most of this growth comes from the biggest players in the sector. Small and medium sized medical research charities are struggling with the challenges they now face in a time of changes to fundraising practices and uncertainty about the future of research when the UK exits the EU.” "To maintain the vital contribution our members make to the UK life sciences sector they need reassurance that they can continue to have access to the best researchers in a post Brexit world to keep the country at the forefront of competitive innovation and drug development.” “Over the 30 years of AMRC, we have campaigned for the best possible environment for health and medical research charities in the UK, tackling the any challenges faced by the medical research sector. We continue to do so and look forward to working with our member charities to ensure patients continue to benefit from the fruits of charitable research investment.” Ends Please contact Leonora Neale ([email protected]; 020 7685 2622) if you would like to request a quote or further information. Notes to editors The Association of Medical Research Charities (AMRC) has been the national membership organisation for the health and medical research charity world for the last 30 years, influencing the policy and research environments by harnessing the collective strengths of our members, to demonstrate the sector’s positive impact on health and wellbeing. AMRC has 140 members which include the largest health and medical charities in the UK: the British Heart Foundation, Cancer Research UK, and the Wellcome Trust. All members, large and small, work to the same high standards ensuring that every pound they spend on research is invested in lifesaving research of the very highest quality. In 2016, health and medical research charities: Invested £1.6bn in research here in the UK, financed capital projects worth £89m, and funded the salaries of at least 17,000 researchers. AMRC supports the use of patient data for medical research when applying the 4Cs (choice, care, competence and clarity) principles. The use of patient data is crucial in advancing medical research and in the care of patients helping to save and improve the lives of nearly half a million people each year. Manage Cookie Preferences
New figures released today reveal that AMRC members funded over £1.6 billion of medical research across the UK in 2016, the biggest proportion of public funding, compared to £1.04 billion from the National Institute for Health Research, and £0.93 billion from the Medical Research Council. This funding stimulated more than £500 million in further investment during 2016 from international funders, government funders, industry, universities and other charities. Aisling Burnand MBE, Chief Executive at AMRC commented: “At a time when there is uncertainty about the potential impact of Brexit on the UK’s medical research sector, it is vital that charitable funding can continue to have such impact. Although we are justly proud of the uniqueness of the role charities have to play in funding UK medical research, we are not complacent about the apparent continued growth. We know that most of this growth comes from the biggest players in the sector. Small and medium sized medical research charities are struggling with the challenges they now face in a time of changes to fundraising practices and uncertainty about the future of research when the UK exits the EU.” "To maintain the vital contribution our members make to the UK life sciences sector they need reassurance that they can continue to have access to the best researchers in a post Brexit world to keep the country at the forefront of competitive innovation and drug development.” “Over the 30 years of AMRC, we have campaigned for the best possible environment for health and medical research charities in the UK, tackling the any challenges faced by the medical research sector. We continue to do so and look forward to working with our member charities to ensure patients continue to benefit from the fruits of charitable research investment.” Ends Please contact Leonora Neale ([email protected]; 020 7685 2622) if you would like to request a quote or further information. Notes to editors The Association of Medical Research Charities (AMRC) has been the national membership organisation for the health and medical research charity world for the last 30 years, influencing the policy and research environments by harnessing the collective strengths of our members, to demonstrate the sector’s positive impact on health and wellbeing. AMRC has 140 members which include the largest health and medical charities in the UK: the British Heart Foundation, Cancer Research UK, and the Wellcome Trust. All members, large and small, work to the same high standards ensuring that every pound they spend on research is invested in lifesaving research of the very highest quality. In 2016, health and medical research charities: Invested £1.6bn in research here in the UK, financed capital projects worth £89m, and funded the salaries of at least 17,000 researchers. AMRC supports the use of patient data for medical research when applying the 4Cs (choice, care, competence and clarity) principles. The use of patient data is crucial in advancing medical research and in the care of patients helping to save and improve the lives of nearly half a million people each year.